SOPHARMA AD (1/2023) Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 23 December 2022.
Report no 1/2023
- 03.01.2023, 09:04
- Kategoria: Biznes i finanse
- Źródło: ESPI
Sopharma AD-BG11SOSOBT18-SOPHARMA
-
-
SOPHARMA AD (103/2022) Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 21 December 2022.
Report no 103/2022- 22.12.2022, 13:37
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (102/2022) Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 21 December 2022.
Report no 102/2022- 22.12.2022, 13:31
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (101/2022) Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 20 December 2022.
Report no 101/2022- 21.12.2022, 10:47
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (100/2022) Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 19 December 2022.
Report no 100/2022- 20.12.2022, 10:42
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (99/2022) Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 15 December 2022.
Report no 99/2022- 19.12.2022, 09:23
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (98/2022) Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 14 December 2022.
Report no 98/2022- 15.12.2022, 15:06
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (97/2022) Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 13 December 2022.
Report no 97/2022- 14.12.2022, 14:02
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (96/2022) Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 9 December 2022.
Report no 96/2022- 12.12.2022, 15:24
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (95/2022) Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 6 December 2022.
Report no 95/2022- 07.12.2022, 12:09
- Kategoria: Biznes i finanse
- Źródło: ESPI
